Eosinophilia-myalgia syndrome associated with L-tryptophan. A case report with pulmonary manifestations and review of the literature.
On October 1989, eosinophilia and incapacitating myalgia, together with arthralgia, dyspnea, cough and edema of the extremities, were shown to be associated with L-tryptophan ingestion. Since then, 1531 cases of eosinophilia-myalgia syndrome have been reported in United States and 22 in Belgium. We report here the unusual pulmonary presentation of this syndrome with a dramatic response of eosinophilia to corticotherapy. The cardio-pulmonary symptoms of eosinophilia-myalgia syndrome and its pathophysiology, which remains unclear, are discussed. The withdrawal of the substance and corticotherapy generally lead to complete recovery although several deaths have been reported.
André
M
M
Service de Médecine Interne, Clinique Notre-Dame, Charleroi.
Canon
J L
JL
Levecque
P
P
Dermine
P
P
Mortier
C
C
Leveau
F
F
D016603:Eosinophilia-Myalgia Syndrome / Q000139:chemically induced* / Q000188:drug therapy / Q000503:physiopathology; D005260:Female; D006801:Humans; D008775:Methylprednisolone / Q000627:therapeutic use; D008875:Middle Aged; D010996:Pleural Effusion / Q000139:chemically induced; D014364:Tryptophan / Q000009:adverse effects*
D014364:Tryptophan; D008775:Methylprednisolone